Johnson & Johnson Expands TECNIS PureSee IOL Access
JACKSONVILLE, Fla., June 11, 2026 Johnson & Johnson has announced the expanded U.S. availability of its TECNIS PureSee Intraocular...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
JACKSONVILLE, Fla., June 11, 2026 Johnson & Johnson has announced the expanded U.S. availability of its TECNIS PureSee Intraocular...
BEIJING, China, June 12, 2026 Datasea Intelligent Technology Ltd. (NASDAQ: DTSS) has announced a significant step forward in its...
CHICAGO, Illinois, May 31, 2026 Johnson & Johnson has reported pivotal results from the Phase 1b/2 OrigAMI-4 study, demonstrating...
MENLO PARK, California, May 31, 2026 GRAIL, Inc. has unveiled compelling new results from its registrational PATHFINDER 2 study,...
SEATTLE and SINGAPORE, May 27, 2026 Callio Therapeutics has announced the presentation of its Phase 1 clinical trial design...
BASEL, Switzerland, May 27, 2026 Roche has announced the launch of its groundbreaking Liver Disease Panel, the healthcare industry’s...
Hong Kong, China, May 25, 2026 Cornerstone Robotics (CSR) has announced that its Sentire® Endoscopic Surgical System has officially...
Boston, Massachusetts, USA, May 21, 2026 Foundation Medicine has announced that the U.S. Food and Drug Administration (FDA) has...
FLAGSTAFF, Ariz., May 11, 2026 Corvention announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance...
Seoul, South Korea | April 24, 2025 CGBIO has achieved a major regulatory milestone with the U.S. Food and...
